Jacobs IJ - Search Results

1

HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer.

Fiegl H, Windbichler G, Mueller-Holzner E, Goebel G, Lechner M, Jacobs IJ, Widschwendter M. Fiegl H, et al. Among authors: jacobs ij. Int J Cancer. 2008 Aug 1;123(3):725-9. doi: 10.1002/ijc.23563. Int J Cancer. 2008. PMID: 18478570 Free article.

2

Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.

Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA, Nelson DL, Berchuck A, Bast RC Jr, Mills GB. Hurteau JA, et al. Among authors: jacobs ij. Cancer. 1995 Nov 1;76(9):1615-20. doi: 10.1002/1097-0142(19951101)76:9<1615::aid-cncr2820760918>3.0.co;2-g. Cancer. 1995. PMID: 8635066 Clinical Trial.

3

Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women.

Jeyarajah AR, Ind TE, Skates S, Oram DH, Jacobs IJ. Jeyarajah AR, et al. Among authors: jacobs ij. Cancer. 1999 May 1;85(9):2068-72. doi: 10.1002/(sici)1097-0142(19990501)85:9<2068::aid-cncr25>3.0.co;2-8. Cancer. 1999. PMID: 10223249 Clinical Trial.

4

High frequency of loss of heterozygosity in vulval intraepithelial neoplasia (VIN) is associated with invasive vulval squamous cell carcinoma (VSCC).

Rosenthal AN, Ryan A, Hopster D, Surentheran T, Jacobs IJ. Rosenthal AN, et al. Among authors: jacobs ij. Int J Cancer. 2001 Dec 15;94(6):896-900. doi: 10.1002/ijc.1549. Int J Cancer. 2001. PMID: 11745496 Free article.

5

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.

Høgdall EV, Ryan A, Kjaer SK, Blaakaer J, Christensen L, Bock JE, Glud E, Jacobs IJ, Høgdall CK. Høgdall EV, et al. Among authors: jacobs ij. Cancer. 2004 Jun 1;100(11):2387-95. doi: 10.1002/cncr.20213. Cancer. 2004. PMID: 15160342 Free article.

6

Screening for ovarian cancer.

Rosenthal AN, Menon U, Jacobs IJ. Rosenthal AN, et al. Among authors: jacobs ij. Clin Obstet Gynecol. 2006 Sep;49(3):433-47. doi: 10.1097/00003081-200609000-00004. Clin Obstet Gynecol. 2006. PMID: 16885651 Review.

7

Epigenetic stem cell signature in cancer.

Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I, Laird PW. Widschwendter M, et al. Nat Genet. 2007 Feb;39(2):157-8. doi: 10.1038/ng1941. Epub 2006 Dec 31. Nat Genet. 2007. PMID: 17200673

8

Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.

Fiegl H, Jones A, Hauser-Kronberger C, Hutarew G, Reitsamer R, Jones RL, Dowsett M, Mueller-Holzner E, Windbichler G, Daxenbichler G, Goebel G, Ensinger C, Jacobs I, Widschwendter M. Fiegl H, et al. Clin Cancer Res. 2008 Jun 1;14(11):3494-502. doi: 10.1158/1078-0432.CCR-07-4557. Clin Cancer Res. 2008. PMID: 18519782 Free article.

9

Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study.

Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, Stegmaier C, Jacobs IJ, Brenner H. Widschwendter M, et al. Among authors: jacobs ij. PLoS One. 2008 Jul 16;3(7):e2656. doi: 10.1371/journal.pone.0002656. PLoS One. 2008. PMID: 18628976 Free PMC article.

10

The effects of common genetic variants in oncogenes on ovarian cancer survival.

Quaye L, Gayther SA, Ramus SJ, Di Cioccio RA, McGuire V, Hogdall E, Hogdall C, Blaakr J, Easton DF, Ponder BA, Jacobs I, Kjaer SK, Whittemore AS, Pearce CL, Pharoah PD, Song H. Quaye L, et al. Clin Cancer Res. 2008 Sep 15;14(18):5833-9. doi: 10.1158/1078-0432.CCR-08-0819. Clin Cancer Res. 2008. PMID: 18794094 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

264 results

Search Page